跳至主要内容
临床试验/NCT06082401
NCT06082401招募中不适用

Evaluating the Addition of Hemodiafiltration to Ex-vivo Lung Perfusion - Impact on the Regeneration of Marginal Donor Lungs: a Prospective Randomized Pilot Study

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
2
主要终点
suitability for transplantation of the lungs after 6 hours of EVLP with HDF

研究概览

简要总结

The primary objective of the study is the evaluation of the effect of hemodiafiltration during ex vivo lung perfusion in marginal donor lungs, and its feasibility. The hypothesis of this study is that this therapy could stabilize perfusate electrolyte composition, remove toxins and waste products, normalize pH levels and prevent edema formation, thereby reconditioning marginal donor lungs for transplantation.

The proposed pilot study addresses the unmet clinical needs in several aspects: a) for the first time a homeostatic device will be introduced in EVLP to reach stable perfusate composition; b) the proposed modification of the standard EVLP could lead to longer perfusion times, making elective transplantation possible and setting the base for possible ex vivo lung treatments; c) the ultimate effect of the proposed study is to increase organ availability through reconditioning of marginal donor lungs.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Marginal donor lungs according to the ISHLT criteria (18)
  • PaO2/FiO2 ratio < 400 (with FiO2=1.0 and PEEP=5-8cmH2O)
  • Donor age ≥ 55 years
  • Smoking history ≥ 20 pack-years
  • Infiltrates in chest radiograph
  • Significant secretions in bronchoscopy
  • Organisms on sputum gram stain
  • Donor age > 18 years

排除标准

  • For donor organs:
  • Bilateral consolidations in donor lungs
  • Lungs from donors with chest trauma
  • Lungs from drowned donors
  • For patients receiving lung transplantation:
  • Inclusions in other interventional studies
  • Patients on the intensive care unit (ICU) prior to transplantation, with mechanical ventilation and/or extracorporeal membrane oxygenation (ECMO) support
  • Re-transplantations

结局指标

主要结局

suitability for transplantation of the lungs after 6 hours of EVLP with HDF

时间窗: 6 hours

PGD grade 3 at 72 hours after transplantation

时间窗: 72 hours

for all transplanted organs

次要结局

  • survival(months)
  • length of ICU stay(up to 100 days)
  • length of hospital stay(up to 200 days)
  • Length of mechanical ventilation(up to 100 days)
  • lung function parameters (MEF50)(24 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alberto Benazzo

Principal Investigator

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验